Open Access
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2018; 76(09): 582-587
DOI: 10.1590/0004-282X20180085
Article

Chronic migraine patients show cognitive impairment in an extended neuropsychological assessment

Pacientes com migrânea crçnica apresentam déficits cognitivos em uma avaliação neuropsicológica estendida
Karen S. Ferreira
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Caroliny T. Teixeira
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Carolina Cáfaro
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Gabriela Z. Oliver
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Gabriela L. P. Carvalho
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Larissa A. S. D. Carvalho
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Brenda G. Silva
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Fernanda B. B. Haes
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
,
Marcelo C. Ciciarelli
1   Centro Universitário Barão de Mauá, Faculdade de Medicina, Neurologia Clínica, Ribeirão Preto SP, Brasil
› Author Affiliations
Preview

ABSTRACT

The objective of the present study was to assess the presence of cognitive deficits in patients with chronic migraine, and to assess the main factors that trigger cognitive disorders, such as comorbidities or the use of medications.

Methods: Chronic migraine and control groups were interviewed in a case-control study. The frequency and intensity of the headache, medication used and associated comorbidities were determined. All patients were submitted to an extended neuropsychological assessment.

Results: The chronic migraine group (n = 30) had a worse performance in the Montreal Cognitive Assessment Test (p = 0.00), Verbal Fluency (p = 0.00), Stroop (p = 0.00), Clock Drawing Test (p = 0.00), Digit Span (p = 0.00) and Matrix Reasoning (p = 0.01). After statistical adjustment by linear regression, migraine continued to be the only relevant factor in the poorer performance in the Montreal Cognitive Assessment, Verbal Fluency, Clock Drawing and Stroop tests.

Conclusion: Patients with chronic migraine have cognitive deficits in multiple tasks, regardless of the presence of comorbidities or the use of medications.

RESUMO

O objetivo do presente estudo foi avaliar a presença de déficits cognitivos em pacientes com migrânea crçnica e avaliar os principais fatores que desencadeiam transtornos cognitivos, como comorbidades e uso de medicações.

Métodos: Pacientes com migrânea crçnica (n = 30) e controles foram entrevistados, em um estudo caso-controle. A frequência e intensidade da cefaleia, medicações utilizadas e comorbidades associadas foram determinadas. Todos os pacientes foram submetidos a uma avaliação neuropsicológica estendida.

Resultados: Os pacientes com migrânea crçnica apresentaram uma pior performance no Montreal Cognitive Assessment (p = 0.00), Fluência Verbal (p = 0.00), Teste de Stroop (p = 0.00), Teste do Relógio (p = 0.00), Subteste Dígitos (p = 0.00) e Raciocínio matricial da WAIS-III (p = 0.01). Após ajuste estatístico através de Regressão Linear, a migrânea se manteve como único fator relevante para pior desempenho em MoCA, Fluência verbal, Teste do relógio e Teste de Stroop.

Conclusão: Pacientes com migrânea crçnica apresentam déficits cognitivos incluindo múltiplas tarefas, independentes da presença de comorbidades e uso de medicações.



Publication History

Received: 21 December 2017

Accepted: 23 May 2018

Article published online:
22 August 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001 Sep;21(7):774-7. https://doi.org/10.1177/033310240102100708
  • 2 Becker WJ, Gladstone JP, Aubé M. Migraine prevalence, diagnosis, and disability. Can J Neurol Sci. 2007 Nov;34(4):S3-9.
  • 3 The International Classification of Headache Disorders: 3nd edition. Cephalalgia, 2013;33(9):644-58.
  • 4 Giacomozzi AR, Vindas AP, Silva AA Jr, Bordini CA, Buonanotte CF, Roesler CA, et al. Latin American consensus on guidelines for chronic migraine treatment. Arq Neuropsiquiatr. 2013 Jul;71(7):478-86. https://doi.org/10.1590/0004-282X20130066
  • 5 Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009 Jun;8(6):560-8. https://doi.org/10.1016/S1474-4422(09)70107-3
  • 6 Aurora SK, Brin MF. Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache. 2017 Jan;57(1):109-25. https://doi.org/10.1111/head.12999
  • 7 McKendrick AM, Badcock DR, Badcock JC, Gurgone M. Motion perception in migraineurs: abnormalities are not related to attention. Cephalalgia. 2006 Sep;26(9):1131-6. https://doi.org/10.1111/j.1468-2982.2006.01182.x
  • 8 Leijdekkers ML, Passchier J, Goudswaard P, Menges LJ, Orlebeke JF. Migraine patients cognitively impaired? Headache. 1990 May;30(6):352-8. https://doi.org/10.1111/j.1526-4610.1990.hed3006352.x
  • 9 Gaist D, Pedersen L, Madsen C, Tsiropoulos I, Bak S, Sindrup S et al. Long-term effects of migraine on cognitive function: a population-based study of Danish twins. Neurology. 2005 Feb;64(4):600-7. https://doi.org/10.1212/01.WNL.0000151858.15482.66
  • 10 Jelicic M, van Boxtel MP, Houx PJ, Jolles J. Does migraine headache affect cognitive function in the elderly? Report from the Maastricht Aging Study (MAAS). Headache. 2000;40:715-719. https://doi.org/10.1212/01.WNL.0000151858.15482.66
  • 11 Pearson AJ, Chronicle EP, Maylor EA, Bruce LA. Cognitive function is not impaired in people with a long history of migraine: a blinded study. Cephalalgia. 2006 Jan;26(1):74-80. https://doi.org/10.1111/j.1468-2982.2005.01001.x
  • 12 Santos-Lasaosa S, Viloria-Alebesque A, Morandeira-Rivas C, Lopez Del Val LJ, Bellosta-Diago E, Velazquez-Benito A. [Mnemonic complaints and chronic migraine]. Rev Neurol. 2013 Aug;57(4):145-9. Spanish.
  • 13 Hooker WD, Raskin NH. Neuropsychologic alterations in classic and common migraine. Arch Neurol. 1986 Jul;43(7):709-12. https://doi.org/10.1001/archneur.1986.00520070065020
  • 14 Zeitlin C, Oddy M. Cognitive impairment in patients with severe migraine. Br J Clin Psychol. 1984 Feb;23(Pt 1):27-35. https://doi.org/10.1111/j.2044-8260.1984.tb00623.x
  • 15 Pellegrino Baena C, Goulart AC, Santos IS, Suemoto CK, Lotufo PA, Bensenor IN. Migraine and cognitive function: Baseline findings from the Brazilian longitudinal study of adult health: ELSA-Brasil. Cephalalgia 2017 Jan 1:333102417737784. https://doi.org/10.1177/0333102417737784
  • 16 Yasuda CL, Centeno M, Vollmar C, Stretton J, Symms M, Cendes F et al. The effect of topiramate on cognitive fMRI. Epilepsy Res. 2013 Jul;105(1-2):250-5. https://doi.org/10.1016/j.eplepsyres.2012.12.007
  • 17 Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J. Topiramate dose effects on cognition: a randomized double-blind study. Neurology. 2011 Jan;76(2):131-7. https://doi.org/10.1212/WNL.0b013e318206ca02
  • 18 Rist PM, Kurth T. Migraine and cognitive decline: a topical review. Headache. 2013 Apr;53(4):589-98. https://doi.org/10.1111/head.12046
  • 19 Rist PM, Dufouil C, Glymour MM, Tzourio C, Kurth T. Migraine and cognitive decline in the population-based EVA study. Cephalalgia. 2011 Sep;31(12):1291-300. https://doi.org/10.1177/0333102411417466
  • 20 American Psychiatry Association. Diagnostic and statistical manual of mental disorders - DSM – 5. 5th ed. Washington: American Psychiatric Association; 2013.
  • 21 Freitas S, Simões MR, Martins C, et al. Estudos de validação do Montreal Cognitive Assessment (Moca) para a população portuguesa. Aval Psi., 2010;9(3):345-57.
  • 22 Stroop R. Studies interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643-62. https://doi.org/10.1037/h0054651
  • 23 Rabelo IS, Pacanaro SV, Rossetti MO, Leme IFAS. Teste das Trilhas Coloridas: manual profissional. São Paulo: Casa do Psicólogo; 2010.
  • 24 Malloy-Diniz LF, Cruz MF, Torres V, Cosenza R. O teste de Aprendizagem Auditivo-Verbal de Rey: normas para uma população brasileira. Rev Bras Neurol. 2000;36(3):79-83.
  • 25 Nascimento E. Adaptação, validação e normatização do WAIS-III para uma amostra brasileira. In: Wechsler D, editor. WAIS-III: manual para administração e avaliação. São Paulo: Casa do Psicólogo; 2004.
  • 26 Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. https://doi.org/10.1037/0022-006X.56.6.893
  • 27 Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4(6):561-71. https://doi.org/10.1001/archpsyc.1961.01710120031004
  • 28 SAS/ STAT User's guide, Version 8. Cary, NC: SAS Institute Inc., 1999. R version 2.8.0 copyright ? 2008.
  • 29 Landrø NI, Fors EA, Våpenstad LL, Holthe Ø, Stiles TC, Borchgrevink PC. The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain. 2013 Jul;154(7):972-7. https://doi.org/10.1016/j.pain.2013.01.013
  • 30 Ferreira KS, Oliver GZ, Thomaz DC, Teixeira CT, Foss MP. Cognitive deficits in chronic pain patients, in a brief screening test, are independent of comorbidities and medication use. Arq Neuropsiquiatr. 2016 May;74(5):361-6. https://doi.org/10.1590/0004-282X20160071